#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	14672	16S	1529	1529	99.93	16S.l15.c17.ctg.1	1960	737.3	0	.	n	.	0	C451T	SNP	451	451	C	659	659	T	906	T,C	865,1	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	14672	16S	1529	1529	99.93	16S.l15.c17.ctg.1	1960	737.3	1	SNP	n	C1184T	0	.	.	1184	1184	C	1392	1392	C	870	C,T	819,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	26592	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3563	744.3	0	.	n	.	0	T695C	SNP	695	695	T	1022	1022	C	785	C	739	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	26592	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3563	744.3	0	.	n	.	0	T1971C	SNP	1971	1971	T	2298	2298	C	849	C,A	801,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	26592	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3563	744.3	1	SNP	n	A2045G	0	.	.	2045	2045	A	2372	2372	A	821	A	789	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	26592	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3563	744.3	1	SNP	n	C2597T	0	.	.	2597	2597	C	2924	2924	C	812	C,G	768,2	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	26592	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3563	744.3	0	HET	.	.	.	A1638G	.	1638	1638	A	1965	1965	A	895	A,G	725,130	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	26592	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3563	744.3	0	HET	.	.	.	G2616A	.	2616	2616	G	2943	2943	G	816	G,A	548,229	.	.
folP.WHO_O_01412c	folP.WHO_O_01412c	1	1	27	2318	folP	855	855	100.0	folP.l6.c30.ctg.1	1569	146.9	1	SNP	p	R229S	1	.	.	685	687	AGC	1028	1030	AGC	211;207;207	A;G;C	203;202;202	folP.WHO_O_01412c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5406	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3552	151.8	1	SNP	p	S91F	1	.	.	271	273	TTC	655	657	TTC	172;175;174	T;T;C	162;165;163	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5406	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3552	151.8	1	SNP	p	G95N	0	.	.	283	285	GGC	667	669	GGC	176;172;171	G;G;C	163;159;162	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5406	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3552	151.8	1	SNP	p	D95G	1	.	.	283	285	GGC	667	669	GGC	176;172;171	G;G;C	163;159;162	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_Y_01506	mtrR.WHO_Y_01506	1	1	27	1740	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1439	120.7	1	SNP	p	G45D	0	.	.	133	135	GGC	542	544	GGC	236;234;235	G;G;C	221;220;223	mtrR.WHO_Y_01506:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	918	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c17.ctg.1	950	95.5	0	.	n	.	0	A197.	DEL	197	197	A	538	538	A	225	A	213	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5130	parC	2304	2304	100.0	parC.l15.c17.ctg.1	2921	175.0	1	SNP	p	D86N	0	.	.	256	258	GAC	558	560	GAC	206;202;203	G;A;C	199;184;195	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5130	parC	2304	2304	100.0	parC.l15.c17.ctg.1	2921	175.0	1	SNP	p	R87W	0	.	.	259	261	CGT	561	563	CGT	205;206;205	C;G;T	194;197;189	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5130	parC	2304	2304	100.0	parC.l15.c17.ctg.1	2921	175.0	1	SNP	p	S87R	1	.	.	259	261	CGT	561	563	CGT	205;206;205	C;G;T	194;197;189	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5130	parC	2304	2304	100.0	parC.l15.c17.ctg.1	2921	175.0	1	SNP	p	R87I	0	.	.	259	261	CGT	561	563	CGT	205;206;205	C;G;T	194;197;189	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5130	parC	2304	2304	100.0	parC.l15.c17.ctg.1	2921	175.0	1	SNP	p	S88P	0	.	.	262	264	TCC	564	566	TCC	208;211;209	T;C;C	195;200;201	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4470	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2621	169.5	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1558	1560	GGC	225;223;222	G;G;C	213;210;205	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	4178	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2457	169.0	1	SNP	p	A311V	0	.	.	931	933	GCC	1296	1298	GCC	225;222;220	G;C;C	213;209;209	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4178	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2457	169.0	1	SNP	p	I312M	1	.	.	934	936	ATG	1299	1301	ATG	222;220;222	A;T;G	210;209;209	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4178	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2457	169.0	1	SNP	p	T316P	0	.	.	946	948	ACC	1311	1313	ACC	212;214;212	A;C,A;C	199;204,1;203	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4178	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2457	169.0	1	SNP	p	V316T	1	.	.	946	948	ACC	1311	1313	ACC	212;214;212	A;C,A;C	199;204,1;203	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4178	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2457	169.0	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1812	1814	ACC	199;200;204	A;C;C	178;184;189	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4178	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2457	169.0	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1866	1868	GCG	217;216;211	G;C;G	203;204;202	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4178	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2457	169.0	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1866	1868	GCG	217;216;211	G;C;G	203;204;202	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4178	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2457	169.0	1	SNP	p	G542S	0	.	.	1624	1626	GGT	1989	1991	GGT	207;205;206	G;G;T	193;192;193	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4178	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2457	169.0	1	SNP	p	G545S	1	.	.	1633	1635	AGC	1998	2000	AGC	201;201;202	A;G;C	190;190;189	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4178	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2457	169.0	1	SNP	p	P551S	0	.	.	1651	1653	CCG	2016	2018	CCG	161;161;161	C,G;C,G;G	123,9;127,3;127	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5872	ponA	2397	2397	100.0	ponA.l6.c4.ctg.1	3015	193.9	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1561	1563	CCG	221;228;226	C;C,T;G	205;214,1;206	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2226	porA	1146	1146	99.91	porA.l6.c4.ctg.1	1786	123.7	0	.	p	.	0	M83fs	FSHIFT	247	247	A	557	557	C	143	C	131	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	278	porB1a	984	271	91.51	porB1a.l15.c17.ctg.2	401	19.3	0	.	p	.	0	A251V	NONSYN	751	753	GCG	72	74	GTA	34;34;34	G;T;A	29;30;30	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	278	porB1a	984	271	91.51	porB1a.l15.c17.ctg.2	401	19.3	0	.	p	.	0	S271T	NONSYN	811	813	TCG	132	134	ACT	43;39;38	A;C;T	39;35;34	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	278	porB1a	984	271	91.51	porB1a.l15.c17.ctg.2	401	19.3	0	.	p	.	0	Y273D	NONSYN	817	819	TAT	138	140	GAT	30;29;27	G;A;T	27;26;26	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	278	porB1a	984	271	91.51	porB1a.l15.c17.ctg.2	401	19.3	0	.	p	.	0	D276N	NONSYN	826	828	GAT	147	149	AAC	27;27;27	A;A;C	26;26;25	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	278	porB1a	984	271	91.51	porB1a.l15.c17.ctg.2	401	19.3	0	.	p	.	0	N277H	NONSYN	829	831	AAC	150	152	CAC	27;27;27	C;A;C	26;25;25	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	278	porB1a	984	271	91.51	porB1a.l15.c17.ctg.2	401	19.3	0	.	p	.	0	R307E	NONSYN	919	921	AGA	240	242	GAA	9;9;9	G;A;A	9;9;9	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	278	porB1a	984	271	91.51	porB1a.l15.c17.ctg.2	401	19.3	0	.	p	.	0	T311A	NONSYN	931	933	ACA	252	254	GCA	11;11;11	G;C;A	11;11;11	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	278	porB1a	984	271	91.51	porB1a.l15.c17.ctg.2	401	19.3	0	.	p	.	0	E312D	NONSYN	934	936	GAA	255	257	GAC	11;11;11	G;A;C	11;11;11	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	278	porB1a	984	271	91.51	porB1a.l15.c17.ctg.2	401	19.3	0	.	p	.	0	F314I	NONSYN	940	942	TTC	261	263	ATC	11;11;11	A;T;C	11;11;11	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	278	porB1a	984	271	91.51	porB1a.l15.c17.ctg.2	401	19.3	0	.	p	.	0	A316S	NONSYN	946	948	GCG	267	269	TCG	11;11;11	T;C;G	11;11;11	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	278	porB1a	984	271	91.51	porB1a.l15.c17.ctg.2	401	19.3	0	.	p	.	0	V318A	NONSYN	952	954	GTC	273	275	GCC	10;10;10	G;C,T;C	10;9,1;10	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	278	porB1a	984	271	91.51	porB1a.l15.c17.ctg.2	401	19.3	0	.	p	.	0	G319S	NONSYN	955	957	GGC	276	278	AGC	10;10;10	A;G;C	10;10;10	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	278	porB1a	984	271	91.51	porB1a.l15.c17.ctg.2	401	19.3	0	.	p	.	0	G320A	NONSYN	958	960	GGT	279	281	GCC	9;9;8	G;C;C	9;9;8	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	278	porB1a	984	271	91.51	porB1a.l15.c17.ctg.2	401	19.3	0	.	p	.	0	G322V	NONSYN	964	966	GGT	285	287	GTT	7;7;7	G;T;T	7;7;7	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2830	porB1b	1038	1038	99.81	porB1b.l15.c4.ctg.1	1679	167.5	0	.	p	.	0	G210R	NONSYN	628	630	GGA	920	922	AGA	256;254;250	A;G;A	246;245;239	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2830	porB1b	1038	1038	99.81	porB1b.l15.c4.ctg.1	1679	167.5	0	.	p	.	0	S217G	NONSYN	649	651	AGT	941	943	GGT	241;242;243	G,A;G;T	232,1;236;236	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2830	porB1b	1038	1038	99.81	porB1b.l15.c4.ctg.1	1679	167.5	1	SNP	p	G120K	1	.	.	358	360	AAG	650	652	AAG	227;228;224	A;A;G	217;218;208	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2830	porB1b	1038	1038	99.81	porB1b.l15.c4.ctg.1	1679	167.5	1	SNP	p	A121N	1	.	.	361	363	AAC	653	655	AAC	221;221;220	A;A;C	210;210;210	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2830	porB1b	1038	1038	99.81	porB1b.l15.c4.ctg.1	1679	167.5	1	SNP	p	N121D	0	.	.	361	363	AAC	653	655	AAC	221;221;220	A;A;C	210;210;210	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	10296	rpoB	4179	4179	99.98	rpoB.l15.c17.ctg.1	4843	212.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1152	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1112	103.1	1	SNP	p	V57M	1	.	.	169	171	ATG	597	599	ATG	240;241;240	A;T;G	227;229;230	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
